January 8, 2019 07:29 AM EST
Financing

Cham­pi­oned by Ab­b­Vie, im­muno-neu­rol­o­gy play­er Alec­tor maps $150M IPO

Natalie Grover

Reporter

En­dorsed by Ab­b­Vie, and un­der the lead­er­ship of Genen­tech vet­er­an Arnon Rosen­thal, San Fran­cis­co-based biotech Alec­tor has chart­ed a path to­ward a $150 mil­lion IPO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times